IRIS
VENTURA, Maria Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.613
EU - Europa 3.581
AS - Asia 3.546
SA - Sud America 975
AF - Africa 138
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.873
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.495
RU - Federazione Russa 1.595
SG - Singapore 1.490
CN - Cina 781
BR - Brasile 778
HK - Hong Kong 503
SE - Svezia 484
DE - Germania 268
UA - Ucraina 267
FI - Finlandia 214
VN - Vietnam 213
FR - Francia 210
IT - Italia 202
GB - Regno Unito 154
IN - India 129
AR - Argentina 74
BD - Bangladesh 67
ID - Indonesia 65
CA - Canada 49
IQ - Iraq 44
MX - Messico 36
TR - Turchia 36
IE - Irlanda 32
PK - Pakistan 29
ZA - Sudafrica 28
CI - Costa d'Avorio 27
ES - Italia 27
VE - Venezuela 26
MA - Marocco 25
BE - Belgio 23
EC - Ecuador 23
AT - Austria 22
UZ - Uzbekistan 22
CO - Colombia 21
JP - Giappone 21
NL - Olanda 20
MY - Malesia 19
SA - Arabia Saudita 17
PH - Filippine 16
AU - Australia 14
PL - Polonia 14
PY - Paraguay 14
CL - Cile 13
JO - Giordania 13
KZ - Kazakistan 12
EG - Egitto 11
LK - Sri Lanka 11
JM - Giamaica 9
LT - Lituania 9
TN - Tunisia 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
KE - Kenya 8
PE - Perù 8
DZ - Algeria 7
IL - Israele 7
CH - Svizzera 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
NP - Nepal 6
PS - Palestinian Territory 6
DO - Repubblica Dominicana 5
PA - Panama 4
RO - Romania 4
BG - Bulgaria 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
PT - Portogallo 3
SO - Somalia 3
AM - Armenia 2
BF - Burkina Faso 2
BY - Bielorussia 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BW - Botswana 1
CG - Congo 1
EE - Estonia 1
Totale 16.853
Salva come PNG Salva come JPEG
Città #
Fairfield 908
Woodbridge 887
Singapore 737
Chandler 720
Ashburn 705
Jacksonville 590
Houston 569
Hong Kong 502
Ann Arbor 383
Nyköping 372
Seattle 361
San Jose 349
Wilmington 314
Cambridge 306
Roxbury 170
Lawrence 169
Lauterbourg 151
Nanjing 143
Beijing 142
New York 127
Des Moines 105
Boardman 103
Los Angeles 85
Helsinki 83
Dallas 75
Ho Chi Minh City 61
São Paulo 60
Inglewood 58
Dong Ket 52
Bari 50
Jiaxing 47
Princeton 47
Hebei 44
Santa Clara 43
Shenyang 43
Brooklyn 37
Jakarta 37
San Diego 37
Nanchang 33
London 30
Tianjin 29
Hanoi 28
Frankfurt am Main 27
Abidjan 26
Council Bluffs 25
Dublin 25
Buffalo 24
Ostuni 24
Montreal 23
Brussels 22
Changsha 19
Nuremberg 19
Paris 19
Rio de Janeiro 19
Tashkent 19
Baghdad 17
Brasília 17
Dearborn 17
Guangzhou 17
Taranto 17
Belo Horizonte 16
Chennai 16
Chicago 16
Curitiba 16
Shanghai 16
Tokyo 16
Pune 15
Colombo 14
Orem 14
Denver 13
Johannesburg 13
Dhaka 12
Moscow 12
Porto Alegre 12
Quito 12
San Francisco 12
Toronto 12
Warsaw 12
Wuhan 12
Campinas 11
Haiphong 11
Istanbul 11
Kuala Lumpur 11
Mexico City 11
Redwood City 11
Amman 10
Atlanta 10
Falkenstein 10
Munich 10
Stockholm 10
Washington 10
Boston 9
Buenos Aires 9
Goiânia 9
Jeddah 9
Phoenix 9
Sydney 9
Vienna 9
Guarulhos 8
Lahore 8
Totale 10.634
Salva come PNG Salva come JPEG
Nome #
Adverse reaction to specific immunotherapy for house-dust mite in a patient with Anisakis allergy 819
Latex allergy and sensitization in cities: a survey in a population at risk. Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):821-30 698
Allergic and psudoallergic reactions induced by glucocorticoids: a review 215
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 175
Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma 160
Anisakiasis, an underestimated infection: effect on intestinal permeability of anisakis simplex- sensitized patients 159
A Multicenter Study of IgE Sensitization to Anisakis simplex and Diet Recommendation 155
2019 ARIA Care pathways for allergen immunotherapy. 154
The work productivity and activity impairment allergic specific (WPAI-AS) questionnaire using mobile technology: The mask study 153
Allergic diseases in the elderly: Biological characteristics and main immunological and non-immunological mechanisms 153
Immunosenescence in aging: between immune cells depletion and cytokines up-regulation 152
Cytokine profile in patients infected with Anisakis simplex in endemic areas: Dietary intervention with polyphenols: A working hypothesis 151
Intramuscular epinephrine as first-line treatment of anaphylaxis: Still concerns about its safety in the elderly? 149
Allergic and non-allergic rhinitis in swimmers: clinical and cytological aspects 147
Allergic bronchial asthma: eosinophil chemotaxis and antihistaminic drug modulation 143
Guidelines for the use and interpretation of diagnostic methods in adult food allergy 142
The Psoriasis pathogenesis and the metabolic risk 141
Management of chronic spontaneous urticaria in the elderly. 140
THE BASOPHIL ACTIVATION TEST IN THE DIAGNOSIS AND MANAGEMENT OF ADVERSE DRUG REACTIONS IN THE ELDERLY 139
Allergic contact dermatitis due to epirubicin 137
Adverse drug reactions as the cause of emergency department admission: focus on the elderly 137
“Importance of hypersensitivity in adverse reactions to drugs in the elderly”. 133
Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 133
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. 132
Antiinflammatory effects of H1-antihistamines: clinical and immunological relevance 131
Books: Fundamentals of Immunology 131
Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy 128
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 128
Sensitization, asthma and allergic disease in young soccer players 126
Anaphylaxis induced by intramuscular betamethasone disodium phosphate: reflections on a clinical case 124
Non-specific immunity in aging: deficiency of monocyte and polymorphonuclear cell-mediated functions 124
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study 122
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly. 121
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. 121
Drug hypersensitivity cutaneous diseases in the elderly 120
Clinical and cytologic characteristics of allergic rhinitis in elderly patients 119
Shrimp allergy: analysis of commercially available extracts for in-vivo diagnosis. 119
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 118
Human melanoma metastasis culture supernatant contains chemotactic factors for phagocytes 117
Adherence issues related to sublingual immunotherapy as perceived by allergists 116
An approach to urticaria in the elderly patients 115
Clusterin serum level: how does it affect psoriatic patients? 115
A survey of clinical features of allergic rhinitis in adults 114
A RETROSPECTIVE SAFETY-MONITORING STUDY OF ADVERSE REACTION OCCURRING DURING IMMUNOTHERAPY: AN EPIDEMIOLOGICAL EVALUATION 113
Contact dermatitis in students practicing sports: incidence of rubber sensitisation 113
Use of complementary medicine among patients with allergic rhinitis: an Italian nationwide survey. 113
Management of allergic disease in the elderly: key considerations,recommendations and emerging therapies 112
Urban air pollution and climate change: "The Decalogue: Allergy Safe Tree" for allergic and respiratory diseases care 112
Modulating effects of monocytes and autologous serum on natural killer capacity in multiple myeloma patients 111
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. 111
Eosinophils in allergic diseases: immunopharmacological regulation 108
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. 108
Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs 107
Lipoprotein-induced inhibition of plaque-forming cell generation and natural killer cell frequency in aged donors 107
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 107
Anisakis simplex hypersensitivity is associated with chronic urticaria in endemic areas. 106
Heterogeneous catalysts for the selective aerobic oxidation of 5-hydroxymethylfurfural to added value products in water 106
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy". 106
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. 105
Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study 105
Allergic contact dermatitis from timolol complicating choroidal melanoma-related glaucoma 103
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 103
Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters 102
Hypersensitivity reactions to complementary and alternative medicine products 102
How to fit allergen immunotherapy in the elderly 102
Latex allergy and sensitization in cities: a survey in a population at risk 100
The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study. 99
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. 99
Advances in diagnosing drug hypersensitivity reactions 98
Anisakis Simplex Infestation and immune-mediated responses. 98
[Cell-mediated immunity in drug addicts: interaction of opiates and naloxone on natural cytotoxic activity and immune-mediated reactions of phagocytes] 98
A critical approach to an allergic paradox: allergic and allergic-like reactions to glucocorticoids. Delayed hypersensitivity mechanisms 97
Is black henna responsible for asthma and cross reactivity with latex? 97
Intestinal permeability in patients with adverse reactions to food 95
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App 95
Sensitization to Horse Allergens in Italy: A Multicentre Study in Urban Atopic Subjects without Occupational Exposure 94
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 94
Relationship between human lipoproteins and interferon-alfa on natural killer cytotoxicity at the single cell level. 93
Incidence of allergic diseases in an elderly population 92
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. 92
Hypersensitivity reactions to ophthalmic products 91
Latex and amoxicillin-provoked occupational asthma 89
. An Update on the Diagnosis of Allergic and Non-Allergic Drug Hypersensitivity 89
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: A SUNFRAIL report 89
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). 89
Cutaneous adverse drug reactions to Fluticasone Propionate and Deflazacort in an asthmatic patient 88
Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients 88
Allergy, asthma and markers of infections among Albanian migrants to Southern Italy 88
Eyedrop-induced allergy: clinical evaluation and diagnostic protocol 87
Effects of in vitro nutrient supplementation on polymorphonuclear cell respiratory burst in primary IgA nephropathy 87
Evaluation of D-dimer levels in obliterating arteriopathies 86
Cross-reactivity in cell-mediated and IgE-mediated hypersensitivity to glucocorticoids 86
The interleukin system (monokines and lymphokines with immunoregulatory action) 85
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2). 84
Anaphylaxis to hydrocortisone hemisuccinate with cross-sensitivity to related compounds in a pediatric patient 82
Determination of total IgA, IgA1 and IgA2 in the serum and saliva of an aged population 81
Vitamin D levels and allergic diseases. An italian cross-sectional multicenter survey. 81
Local and systemic reaction occurring during immunotherapy: an epidemiological evaluation and a prospective safety-monitoring study 81
In vitro modulating effect of zinc chloride and human lipoproteins on phagocytic activity in the elderly. 80
Effect of budesonide on eosinophil chemotactic activity in allergic patients 79
Totale 12.639
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 0 0 0 0 0 0 204 69 129
2021/2022957 27 90 8 72 46 71 26 61 75 62 157 262
2022/20231.844 268 152 138 204 233 255 13 165 350 13 33 20
2023/2024576 49 129 25 22 33 133 9 22 20 23 24 87
2024/20252.397 130 33 258 59 64 203 147 172 125 102 367 737
2025/20265.421 656 168 350 570 481 272 654 145 1.734 391 0 0
Totale 17.156